CF PHARMTECH (02652) spent HK$366,900 on May 14 to repurchase 17,500 shares.
Chang Feng Pharmaceuticals (02652) announced that on May 14, 2026, the company spent HK$366,900 to repurchase 17,500 shares at a repurchase price of HK$20.68-21.42 per share.
CF PHARMTECH (02652) announced that the company repurchased 17,500 shares at a total cost of 366,900 Hong Kong dollars on May 14, 2026, with a repurchase price of 20.68-21.42 Hong Kong dollars per share.
Related Articles
Shandong Sanyuan Biotechnology (301206.SZ) plans to introduce a restricted stock incentive plan in 2026.
Zhejiang Meorient Commerce & Exhibition Inc. (300795.SZ) is planning to subscribe to 150 million yuan of shares in Shanghai Jiayue Xingchen Intelligent Technology Co., Ltd.
A-share Evening Hotspots | Yushu Technology's Sci-Tech Innovation Board IPO will be reviewed on June 1, and multiple stock announcements suggest risks.
Shandong Sanyuan Biotechnology (301206.SZ) plans to introduce a restricted stock incentive plan in 2026.
Zhejiang Meorient Commerce & Exhibition Inc. (300795.SZ) is planning to subscribe to 150 million yuan of shares in Shanghai Jiayue Xingchen Intelligent Technology Co., Ltd.
A-share Evening Hotspots | Yushu Technology's Sci-Tech Innovation Board IPO will be reviewed on June 1, and multiple stock announcements suggest risks.
